INTACT BREAST LESION EXCISION SYSTEM WITH INTACT EXCISION XL

Instrument, Biopsy

INTACT MEDICAL CORPORATION

The following data is part of a premarket notification filed by Intact Medical Corporation with the FDA for Intact Breast Lesion Excision System With Intact Excision Xl.

Pre-market Notification Details

Device IDK081057
510k NumberK081057
Device Name:INTACT BREAST LESION EXCISION SYSTEM WITH INTACT EXCISION XL
ClassificationInstrument, Biopsy
Applicant INTACT MEDICAL CORPORATION ONE APPLE HILL SUITE 316 Natick,  MA  01760
ContactDouglas Macarthur
CorrespondentDouglas Macarthur
INTACT MEDICAL CORPORATION ONE APPLE HILL SUITE 316 Natick,  MA  01760
Product CodeKNW  
CFR Regulation Number876.1075 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2008-04-14
Decision Date2008-06-17
Summary:summary

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.